2 completed, 2 unknown. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow E1224: new trials by email Literature Review of E1224 trials Research Report on E1224
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proof-of-Concept Superiority Trial of Fosravuconazole Versus Itraconazole for Eumycetoma in Sudan Fosravuconazole, Itraconazole - Mycetoma | Phase 2 | Completed | Drugs for Neglected Diseases | 104 | 2017-05-09 | 2024-07-18 |
| BENDITA BEnznidazole New Doses Improved Treatment and Associations Benznidazole, E1224, E1224 Placebo - Chagas Disease | Phase 2 | Unknown | Drugs for Neglected Diseases | 210 | 2016-11-30 | 2017-12-20 |
| Pharmacokinetic Drug-Drug Interaction Study Benznidazole, E1224 - Chagas Disease | Phase 1 | Completed | Drugs for Neglected Diseases | 28 | 2014-10-01 | 2019-03-27 |
| Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease E1224, Benznidazole, Placebo - Chronic Chagas Disease, Indeterminate | Phase 2 | Unknown | Drugs for Neglected Diseases | 230 | 2011-06-01 | 2011-12-21 |
Chagas Disease (3) · Bronchiolitis Obliterans Syndrome (1) · Mycetoma (1)
Drugs for Neglected Diseases (4)
Bolivia (2) · Argentina (1) · Sudan (1)
Faustino Torrico, PhD (2) · Isabela Ribeiro, MD (2) · Ahmed Fahal, Prof (1) · Ethel Feleder, MD (1)
PMID 29352704, PMID 30509941, PMID 33836161, PMID 36409773, PMID 39098321, PMID 39627222, PMID 40433693, PMID 40982532